Domesco Medical Import Export JSCSTC:DMC 78 Return-on-Tangible-Equity is 12.73% as of Mar. 2026, which is 13% below its 10-year median of 14.58. GuruFocus rates STC:DMC with a GF Score™ of 78/100 and a GF Value™ of ₫73,609.51 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 898 Drug Manufacturers companies, Domesco Medical Import Export JSC ranks better than 65.59% on this metric.
The historical rank and industry rank for Domesco Medical Import Export JSC's Return-on-Tangible-Equity or its related term are showing as below:
STC:DMC'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 12.3 Med: 14.58 Max: 23.89
Current: 12.75
During the past 13 years, Domesco Medical Import Export JSC's highest Return-on-Tangible-Equity was 23.89%. The lowest was 12.30%. And the median was 14.58%.
STC:DMC's Return-on-Tangible-Equity is ranked better than 65.59% of 898
companies
in the Drug Manufacturers industry
Industry Median: 7.88
vs STC:DMC: 12.75
Domesco Medical Import Export JSC (STC:DMC) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Domesco Medical Import Export JSC Return-on-Tangible-Equity Related Terms
Domesco Medical Import Export JSC Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Domesco Medical Import Export JSC Return-on-Tangible-Equity Chart
STC:DMC vs ZTS, UTHR: Return-on-Tangible-Equity Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Domesco Medical Import Export JSC's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Domesco Medical Import Export JSC Return-on-Tangible-Equity vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Domesco Medical Import Export JSC's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Domesco Medical Import Export JSC's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 12.73% mean?
Domesco Medical Import Export JSC (STC:DMC) has a Return-on-Tangible-Equity of 12.73% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Domesco Medical Import Export JSC and its competitors. This is 13% below median its historical median of 14.58. Over the past decade, Domesco Medical Import Export JSC's Return-on-Tangible-Equity has ranged from 12.30 to 23.89. According to the industry distribution chart, Domesco Medical Import Export JSC ranks #309 out of 898 companies in the Drug Manufacturers industry, placing it in the top 34.4%.
Is Domesco Medical Import Export JSC's Return-on-Tangible-Equity too high?
Domesco Medical Import Export JSC's current Return-on-Tangible-Equity of 12.73% is 13% below median its 10-year median of 14.58. Over the past 10 years, this metric has ranged from a low of 12.30 to a high of 23.89. The Drug Manufacturers industry median Return-on-Tangible-Equity is 7.88. Domesco Medical Import Export JSC's value of 12.73% is 61.5% above this industry median. Based on the distribution chart, Domesco Medical Import Export JSC ranks #309 out of 898 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Domesco Medical Import Export JSC has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Domesco Medical Import Export JSC's Return-on-Tangible-Equity compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Domesco Medical Import Export JSC ranks #309 out of 898 companies for Return-on-Tangible-Equity. This puts Domesco Medical Import Export JSC in the upper half of its industry. The industry median Return-on-Tangible-Equity is 7.88. Domesco Medical Import Export JSC's value of 12.73% is 61.5% above this benchmark. Historically, Domesco Medical Import Export JSC's own Return-on-Tangible-Equity has ranged from 12.30 to 23.89 over the past decade. While the company's 10-year median is 14.58 vs. the industry median of 7.88, Domesco Medical Import Export JSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Drug Manufacturers company?
The median Return-on-Tangible-Equity among Drug Manufacturers companies is 7.88, based on 898 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Domesco Medical Import Export JSC's current Return-on-Tangible-Equity of 12.73% is 61.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Domesco Medical Import Export JSC and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Equity is 7.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Domesco Medical Import Export JSC's current Return-on-Tangible-Equity is 12.73%, which is 13% below median its own 10-year median of 14.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Domesco Medical Import Export JSC stock overvalued right now?
Based on GuruFocus' analysis, Domesco Medical Import Export JSC (STC:DMC) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫73,609.51, compared to a current price of ₫59,000.00 — trading 19.8% below its estimated fair value. The current Return-on-Tangible-Equity is 12.73%, which is 13% below median its 10-year median of 14.58 and 61.5% above the Drug Manufacturers industry median of 7.88. Domesco Medical Import Export JSC's overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Domesco Medical Import Export JSC (STC:DMC), the current Return-on-Tangible-Equity is 12.73% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Domesco Medical Import Export JSC (STC:DMC) Overvalued in 2026?
Based on GuruFocus' analysis, Domesco Medical Import Export JSC stock appears to be undervalued.
The current stock price of ₫59,000.00 is trading 19.8% below its estimated GF Value™ of ₫73,609.51.
GuruFocus considers Domesco Medical Import Export JSC to be Modestly Undervalued.
Key valuation signals for STC:DMC:
Return-on-Tangible-Equity: 12.73% (13% below median its 10-year median of 14.58)
GF Value™: ₫73,609.51 vs. price of ₫59,000.00 (19.8% below fair value)
Industry Position: 61.5% above the Drug Manufacturers median (#309 of 898)
No single metric tells the full story. See the STC:DMC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Domesco Medical Import Export JSC Business Description
Domesco Medical Import Export JSC is specialized in research, development, production, marketing and trading of Pharmaceuticals, medicines derived from Pharmaceutical materials, functional food, pure drinking water and medical beverages. It operates in import and export of medicines, medicine materials, food - functional foods, medical supplies, and medical equipment for medical examination and treatment for the whole people.
78GF Score
Get the complete analysis for STC:DMC
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:DMC has been successfully added to your 
